MY ACCOUNT | NEWSLETTER |

Prevalence of Feline Leukemia Virus and Antibodies to Feline Immunodeficiency Virus in Cats in Norway


Serum samples from 224 Norwegian cats were analyzed for the presence of feline leukemia virus (FeLV) p27 common core antigen, and for antibodies to feline immunodeficiency virus (FIV). Ninety specimens originated from the serum bank at the central referral clinic at the Norwegian College of Veterinary Medicine, which had been collected during the years 1983–1989; 67 sera were submitted from veterinarian practitioners; while 67 sera originated from cats presented for euthanasia. The cats were classified into one “healthy” and one “sick” group.

Only 2.2 % of sick cats and 1.2 % of healthy cats showed FeLV antigenemia, a finding which is lower than which has been reported from many other countries.

The prevalence of FIV antibodies was 10.1 % in sick cats and 5.9 % in healthy cats. Antibodies to FIV was most prevalent in male cats (14.7%) than in female cats (2.1 %), and more prevalent among domestic cats (12.0 %) compared to pedigree cats (2.4 %). Antibodies to FIV in the cats demonstrated increasing prevalence with increasing age. It may be concluded that FeLV causes minor problems in Norwegian cats, while FIV is present in a similar prevalence to what is reported form other countries.


Authors: K. Ueland, H. Lutz

Source: https://onlinelibrary.wiley.com/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

WSU’s Good Samaritan Fund puts loving pitbull back on her feet

Like0
Dislike0

Small Door Veterinary Strengthens Executive Team as It Enters Next Phase of Growth

Like0
Dislike0

Reduced tear production in three canine endocrinopathies

Like0
Dislike0

Characterization of E. coli associated with high mortality in poultry flocks

Like0
Dislike0

WSU receives grant to test new rabies control strategy

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top